Historique
Article de Périodique
Misuse of medicines in the European union: a systematic review of the literature (2012)
Auteur(s) :
CASATI, A. ;
SEDEFOV, R. ;
PFEIFFER-GERSCHEL, T.
Année :
2012
Page(s) :
228-245
Sous-type de document :
Revue de la littérature / Literature review
Langue(s) :
Anglais
Refs biblio. :
81
Domaine :
Autres substances / Other substances
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus géographique
EUROPE
;
UNION EUROPEENNE
Thésaurus mots-clés
MEDICAMENTS
;
ANALGESIQUES
;
OPIOIDES
;
HYPNOTIQUES
;
ABUS
;
METHADONE
;
BUPRENORPHINE
;
DEPENDANCE
;
PRODUIT DE SUBSTITUTION
;
MESUSAGE
;
PREVALENCE
Résumé :
Background: Although awareness of the misuse of medicines is increasing, data on the extent of the problem in the European Union (EU) are lacking.
Methods: In order to assess the magnitude and severity of the problem, a systematic review of the literature on the misuse of analgesics, opioid substitution medicines and sedatives/hypnotics (with the exception of benzodiazepines) was conducted using the PubMed and Web of Science databases. Relevant literature was identified between 2001 and 2011.
Results: The main groups of misused medicines include opioid analgesics, methadone, buprenorphine and Z-drugs. Regional trends in medicine misuse indicate heterogeneity across the EU with respect to misused medicine types and research activities. Prevalence, high-risk populations and factors contributing to medicine misuse are discussed.
Conclusion: The implications of these findings for prevention, treatment, and policy in the EU are considered.
Methods: In order to assess the magnitude and severity of the problem, a systematic review of the literature on the misuse of analgesics, opioid substitution medicines and sedatives/hypnotics (with the exception of benzodiazepines) was conducted using the PubMed and Web of Science databases. Relevant literature was identified between 2001 and 2011.
Results: The main groups of misused medicines include opioid analgesics, methadone, buprenorphine and Z-drugs. Regional trends in medicine misuse indicate heterogeneity across the EU with respect to misused medicine types and research activities. Prevalence, high-risk populations and factors contributing to medicine misuse are discussed.
Conclusion: The implications of these findings for prevention, treatment, and policy in the EU are considered.
Affiliation :
Institut für Therapieforschung, Munich, Germany
Cote :
Abonnement